{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:46:54Z","timestamp":1782776814857,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ejogrb.2026.115065","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:35:59Z","timestamp":1773048959000},"page":"115065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Beyond recurrence detection: Treating the forgotten menopause in endometrial cancer survivors"],"prefix":"10.1016","volume":"321","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6618-045X","authenticated-orcid":false,"given":"Wiebren","family":"Tjalma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Servayge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevilay","family":"Altintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2026.115065_b0005","article-title":"Cancer today International Agency for Research on Cancer, Cancer incidence and mortality statistics worldwide and by region","author":"Iarc","year":"2025","journal-title":"Corpus Uteri Cancer Today"},{"key":"10.1016\/j.ejogrb.2026.115065_b0010","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2147\/IJWH.S499435","article-title":"Global Trends in Incidence and Mortality rates of Endometrial Cancer among individuals Aged 55 years and above from 1990 to 2021: an Analysis of the Global Burden of Disease","volume":"17","author":"Gao","year":"2025","journal-title":"Int J Womens Health"},{"issue":"5","key":"10.1016\/j.ejogrb.2026.115065_b0015","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.ajog.2023.07.002","article-title":"Please do not harm asymptomatic postmenopausal women with a vaginal ultrasound","volume":"229","author":"Tjalma","year":"2023","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115065_b0020","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.annonc.2023.10.118","article-title":"There is no place for ovarian cancer screening in hereditary breast-ovarian cancer syndromes","volume":"35","author":"Tjalma","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejogrb.2026.115065_b0025","article-title":"National Cancer Institute Surveillance Epidemiology and end results (SEER)","author":"Seer","year":"2025","journal-title":"Program Cancer Stat Facts: Uterine Cancer"},{"issue":"10","key":"10.1016\/j.ejogrb.2026.115065_b0030","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/cvr\/cvaf086","article-title":"From sex hormone decrease to hormonal treatment: impacts on cardiovascular risk with ageing","volume":"121","author":"Fontaine","year":"2025","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ejogrb.2026.115065_b0035","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.maturitas.2020.01.005","article-title":"European Menopause and Andropause Society (EMAS) and International Gynecologic Cancer Society (IGCS) position statement on managing the menopause after gynecological cancer: focus on menopausal symptoms and osteoporosis","volume":"134","author":"Rees","year":"2020","journal-title":"Maturitas"},{"issue":"5","key":"10.1016\/j.ejogrb.2026.115065_b0040","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1136\/ijgc-00009577-200409000-00029","article-title":"The clinical value and the cost-effectiveness of follow-up in endometrial cancer patients","volume":"14","author":"Tjalma","year":"2004","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"10.1016\/j.ejogrb.2026.115065_b0045","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1016\/S1470-2045(25)00167-6","article-title":"ESGO-ESTRO-ESP guidelines for the management of patients with endometrial carcinoma: update 2025","volume":"26","author":"Concin","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejogrb.2026.115065_b0050","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines \u00ae). Uterine Neoplasms. 2026;Version 2.2026."},{"issue":"4","key":"10.1016\/j.ejogrb.2026.115065_b0055","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/JCO.2005.02.8464","article-title":"Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study","volume":"24","author":"Barakat","year":"2006","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ejogrb.2026.115065_b0060","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ejca.2014.03.006","article-title":"Effects of hormone replacement therapy on the rate of recurrence in endometrial cancer survivors: a meta-analysis","volume":"50","author":"Shim","year":"2014","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.ejogrb.2026.115065_b0065","article-title":"Hormone replacement therapy for women previously treated for endometrial cancer","volume":"5","author":"Edey","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"14","key":"10.1016\/j.ejogrb.2026.115065_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10143165","article-title":"Hormone Replacement Therapy in Endometrial Cancer Survivors: a Meta-Analysis","volume":"10","author":"Londero","year":"2021","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.115065_b0075","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.3802\/jgo.2019.30.e51","article-title":"Effects of hormone therapy on recurrence in endometrial cancer survivors: a nationwide study using the Korean Health Insurance Review and Assessment Service database","volume":"30","author":"Cho","year":"2019","journal-title":"J Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2026.115065_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2025.101239","article-title":"Hormone replacement therapy in endometrial cancer survivors: a retrospective cohort study on recurrence, survival, and quality of life","volume":"58","author":"Xing","year":"2025","journal-title":"Curr Probl Cancer"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.115065_b0085","first-page":"555","article-title":"Estrogen replacement therapy in endometrial cancer patients: a matched control study","volume":"97","author":"Suriano","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.115065_b0090","first-page":"195","article-title":"Does Hormone Replacement Therapy Impact the Prognosis in Endometrial Cancer Survivors?","volume":"98","author":"Di Donato","year":"2020","journal-title":"A Systematic Review Oncology"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115065_b0095","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-5122(98)00025-5","article-title":"Constructing a standard climacteric scale","volume":"29","author":"Greene","year":"1998","journal-title":"Maturitas"},{"issue":"6","key":"10.1016\/j.ejogrb.2026.115065_b0100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0025-7753(04)74198-6","article-title":"Health-related quality of life in the spanish women through and beyond menopause. Development and validation of the Cervantes Scale","volume":"122","author":"Palacios","year":"2004","journal-title":"Med Clin (Barc)"},{"issue":"5","key":"10.1016\/j.ejogrb.2026.115065_b0105","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1097\/gme.0b013e318167b916","article-title":"Understanding how personality factors may influence quality of life: development and validation of the Cervantes Personality Scale","volume":"15","author":"Castelo-Branco","year":"2008","journal-title":"Menopause"},{"key":"10.1016\/j.ejogrb.2026.115065_b0110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejogrb.2020.06.019","article-title":"Women with low quality of life by cervantes-short form scale choose menopausal hormone therapy","volume":"252","author":"Fasero","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115065_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2023.101815","article-title":"Progestogens for endometrial protection in combined menopausal hormone therapy: a systematic review","volume":"38","author":"Stute","year":"2024","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.115065_b0120","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/13697137.2016.1187123","article-title":"The impact of micronized progesterone on the endometrium: a systematic review","volume":"19","author":"Stute","year":"2016","journal-title":"Climacteric"},{"issue":"12","key":"10.1016\/j.ejogrb.2026.115065_b0125","doi-asserted-by":"crossref","first-page":"e1846","DOI":"10.1634\/theoncologist.2020-0417","volume":"25","author":"S\u00e1nchez-Rovira","year":"2020","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.115065_b0130","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/ijgc-2019-001034","article-title":"Vaginal estrogen use for genitourinary symptoms in women with a history of uterine, cervical, or ovarian carcinoma","volume":"30","author":"Chambers","year":"2020","journal-title":"Int J Gynecol Cancer"},{"issue":"31","key":"10.1016\/j.ejogrb.2026.115065_b0135","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1200\/JCO.19.01696","article-title":"Management of Osteoporosis in Survivors of Adult Cancers with Nonmetastatic Disease: ASCO Clinical Practice Guideline","volume":"37","author":"Shapiro","year":"2019","journal-title":"J Clin Oncol"},{"issue":"10430","key":"10.1016\/j.ejogrb.2026.115065_b0140","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0140-6736(23)02802-7","article-title":"Managing menopause after cancer","volume":"403","author":"Hickey","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2026.115065_b0145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bpobgyn.2021.09.012","article-title":"Alternative and non-hormonal treatments to symptoms of menopause","volume":"81","author":"Djapardy","year":"2022","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.115065_b0150","doi-asserted-by":"crossref","first-page":"297","DOI":"10.52054\/FVVO.15.4.102","article-title":"Clinical guidelines for managing menopausal symptoms in women with (a history of) breast cancer","volume":"15","author":"Servayge","year":"2023","journal-title":"Facts Views Vis Obgyn"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.115065_b0155","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/jama.2020.9482","article-title":"Association of Menopausal Hormone Therapy with Breast Cancer Incidence and Mortality during Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials","volume":"324","author":"Chlebowski","year":"2020","journal-title":"J Am Med Assoc"},{"issue":"14","key":"10.1016\/j.ejogrb.2026.115065_b0160","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial","volume":"291","author":"Anderson","year":"2004","journal-title":"J Am Med Assoc"},{"issue":"5","key":"10.1016\/j.ejogrb.2026.115065_b0165","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S1470-2045(12)70075-X","article-title":"Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial","volume":"13","author":"Anderson","year":"2012","journal-title":"Lancet Oncol"},{"issue":"9382","key":"10.1016\/j.ejogrb.2026.115065_b0170","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(03)14066-4","article-title":"Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk","volume":"362","author":"Scarabin","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejogrb.2026.115065_b0175","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1161\/ATVBAHA.109.196022","article-title":"Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study","volume":"30","author":"Canonico","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1016\/j.ejogrb.2026.115065_b0180","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/CIRCULATIONAHA.106.642280","article-title":"Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study","volume":"115","author":"Canonico","year":"2007","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.ejogrb.2026.115065_b0185","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1111\/j.1538-7836.2006.01933.x","article-title":"Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration","volume":"4","author":"Canonico","year":"2006","journal-title":"The ESTHER Study J Thromb Haemost"},{"issue":"13","key":"10.1016\/j.ejogrb.2026.115065_b0190","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1505241","article-title":"Vascular Effects of Early versus late Postmenopausal Treatment with Estradiol","volume":"374","author":"Hodis","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115065_b0195","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13148-022-01311-w","article-title":"Effect of menopausal hormone therapy on methylation levels in early and late postmenopausal women","volume":"14","author":"Hilser","year":"2022","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.ejogrb.2026.115065_b0200","doi-asserted-by":"crossref","unstructured":"Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, et al. KEEPS: The Kronos Early Estrogen Prevention Study. Climacteric. 8. England2005. p. 3-12.","DOI":"10.1080\/13697130500042417"},{"issue":"2","key":"10.1016\/j.ejogrb.2026.115065_b0205","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/13697137.2020.1804545","article-title":"Lessons from KEEPS: the Kronos Early Estrogen Prevention Study","volume":"24","author":"Miller","year":"2021","journal-title":"Climacteric"},{"key":"10.1016\/j.ejogrb.2026.115065_b0210","first-page":"65","article-title":"Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions","volume":"166","author":"Mendoza","year":"2022","journal-title":"MHT Eligibility Criteria Group Maturitas"},{"key":"10.1016\/j.ejogrb.2026.115065_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2024.108055","article-title":"Sexual health and wellbeing and the menopause: an EMAS clinical guide","volume":"189","author":"Paschou","year":"2024","journal-title":"Maturitas"},{"issue":"8","key":"10.1016\/j.ejogrb.2026.115065_b0220","doi-asserted-by":"crossref","first-page":"412","DOI":"10.5498\/wjp.v11.i8.412","article-title":"Menopause and cognitive impairment: a narrative review of current knowledge","volume":"11","author":"Conde","year":"2021","journal-title":"World J Psychiatry"},{"key":"10.1016\/j.ejogrb.2026.115065_b0225","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.maturitas.2021.06.006","article-title":"Global consensus recommendations on menopause in the workplace: a European Menopause and Andropause Society (EMAS) position statement","volume":"151","author":"Rees","year":"2021","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115065_b0230","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s41687-025-00875-4","article-title":"Psychometric evaluation of the HFDD, PROMIS SD SF 8b, and MENQOL questionnaire in women experiencing vasomotor symptoms associated with menopause","volume":"9","author":"Trigg","year":"2025","journal-title":"J Patient Rep Outcomes"},{"key":"10.1016\/j.ejogrb.2026.115065_b0235","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ygyno.2024.06.020","article-title":"Effect of reduced follow-up care on patient satisfaction with care among patients with endometrial cancer: the ENSURE randomized controlled trial","volume":"188","author":"Ezendam","year":"2024","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.ejogrb.2026.115065_b0240","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1200\/JOP.19.00801","article-title":"Survivorship Care Plans and the Commission on Cancer Standards: the increasing need for Better strategies to Improve the Outcome for Survivors of Cancer","volume":"16","author":"Blaes","year":"2020","journal-title":"JCO Oncol Pract"},{"issue":"9","key":"10.1016\/j.ejogrb.2026.115065_b0245","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.3390\/curroncol31090412","article-title":"The Quality of Life after Endometrial Cancer Study: Baseline Characteristics and Patient-Reported Outcomes","volume":"31","author":"Warring","year":"2024","journal-title":"Curr Oncol"},{"key":"10.1016\/j.ejogrb.2026.115065_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejogrb.2025.114108","article-title":"Diagnostic performances of hysteroscopy in post-remission surveillance of patients treated conservatively for endometrial cancer and atypical hyperplasia: a cohort study","volume":"312","author":"Vasileva","year":"2025","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"10.1016\/j.ejogrb.2026.115065_b0255","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1136\/ijgc-00009577-200509000-00050","article-title":"Routine follow-up in cancer patients appears to be a precious ritual","volume":"15","author":"Tjalma","year":"2005","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"10.1016\/j.ejogrb.2026.115065_b0260","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/ijc.30470","article-title":"High cardiovascular disease mortality after endometrial cancer diagnosis: results from the Surveillance, Epidemiology, and end results (SEER) Database","volume":"140","author":"Felix","year":"2017","journal-title":"Int J Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.ejogrb.2026.115065_b0265","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ijgo.70326","article-title":"Cancer of the corpus uteri: a 2025 update","volume":"171","author":"Koskas","year":"2025","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"10.1016\/j.ejogrb.2026.115065_b0270","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ygyno.2017.11.019","article-title":"The unrecognized burden of cardiovascular risk factors in women newly diagnosed with endometrial cancer: a prospective case control study","volume":"148","author":"Kitson","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejogrb.2026.115065_b0275","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/20533691241286666","article-title":"British Gynaecological Cancer Society and British Menopause Society guidelines: Management of menopausal symptoms following treatment of gynaecological cancer","volume":"30","author":"Taylor","year":"2024","journal-title":"Post Reprod Health"},{"issue":"10","key":"10.1016\/j.ejogrb.2026.115065_b0280","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/jama.2017.11217","article-title":"Menopausal Hormone Therapy and long-term All-Cause and Cause-specific Mortality: the Women's Health Initiative Randomized Trials","volume":"318","author":"Manson","year":"2017","journal-title":"J Am Med Assoc"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211526001314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211526001314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T23:09:20Z","timestamp":1782774560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211526001314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":56,"alternative-id":["S0301211526001314"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2026.115065","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond recurrence detection: Treating the forgotten menopause in endometrial cancer survivors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2026.115065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115065"}}